Get the Stockscreener App
436.95
1.62%
-7.20
Waters Corp stock is traded at $436.95, with a volume of 902.30K.
It is down -1.62% in the last 24 hours and up +4.37% over the past month.
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools.
See More
Previous Close:
$444.15
Open:
$444.48
24h Volume:
902.30K
Relative Volume:
0.92
Market Cap:
$42.93B
Revenue:
$3.77B
Net Income/Loss:
$449.25M
P/E Ratio:
55.62
EPS:
7.8556
Net Cash Flow:
$240.68M
1W Performance:
+0.73%
1M Performance:
+4.37%
6M Performance:
+36.96%
1Y Performance:
+30.48%
1-Day Range:
$431.99
$448.39
1-Week Range:
$422.82
$449.12
52-Week Range:
$282.77
$454.54
Waters Corp Stock (WAT) Company Profile
Name
Waters Corp
Sector
Industry
Phone
(508) 478-2000
Address
34 MAPLE ST, MILFORD, MA
Compare WAT vs TMO, DHR, NTRA, A, IDXX
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WAT
Waters Corp
|
436.95 | 42.93B | 3.77B | 449.25M | 240.68M | 7.8556 |
TMO
Thermo Fisher Scientific Inc
|
690.00 | 255.13B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
229.04 | 161.01B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
393.44 | 56.71B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
172.97 | 48.77B | 7.23B | 1.41B | 1.09B | 4.979 |
IDXX
Idexx Laboratories Inc
|
560.36 | 44.15B | 4.45B | 1.10B | 1.06B | 13.59 |
Waters Corp Stock (WAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-09-26 | Resumed | UBS | Buy |
| Aug-27-26 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-05-26 | Upgrade | TD Cowen | Hold → Buy |
| Jul-09-26 | Initiated | RBC Capital Mkts | Outperform |
| Jun-26-26 | Resumed | Bernstein | Outperform |
| Jun-11-26 | Initiated | Piper Sandler | Neutral |
| Jun-02-26 | Resumed | Wolfe Research | Outperform |
| Apr-06-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Feb-10-26 | Resumed | Barclays | Overweight |
| Feb-10-26 | Resumed | Citigroup | Buy |
| Feb-10-26 | Resumed | Evercore ISI | In-line |
| Jan-06-26 | Initiated | Guggenheim | Buy |
| Jan-05-26 | Initiated | William Blair | Outperform |
| Dec-10-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-02-25 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-08-25 | Initiated | Rothschild & Co Redburn | Buy |
| Mar-31-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-26-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-13-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Feb-10-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-10-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Oct-08-24 | Upgrade | Jefferies | Hold → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Aug-01-24 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Nov-13-23 | Downgrade | Barclays | Equal Weight → Underweight |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Jul-20-22 | Initiated | UBS | Neutral |
| May-18-22 | Initiated | Barclays | Overweight |
| May-17-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Apr-25-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Jul-06-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-07-21 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Dec-17-20 | Upgrade | Cleveland Research | Underperform → Buy |
| Dec-16-20 | Upgrade | Citigroup | Sell → Neutral |
| Dec-02-20 | Initiated | Goldman | Neutral |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-28-20 | Upgrade | JP Morgan | Underweight → Neutral |
| Jul-16-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jan-08-20 | Downgrade | Needham | Hold → Underperform |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Initiated | Citigroup | Sell |
| Nov-15-19 | Initiated | Stifel | Hold |
| Oct-09-19 | Downgrade | Barclays | Equal Weight → Underweight |
| Jul-16-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jun-12-19 | Downgrade | Cleveland Research | Neutral → Underperform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| Jan-24-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-03-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jan-03-19 | Initiated | Needham | Hold |
| Dec-12-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-30-18 | Downgrade | Goldman | Neutral → Sell |
| Oct-11-18 | Upgrade | Cleveland Research | Sell → Neutral |
View All
Waters Corp Stock (WAT) Latest News
Should You Invest in the First Trust Water ETF (FIW)? - Zacks Investment Research
Waters Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Here's Why You Should Retain WAT Stock in Your Portfolio for Now - Zacks Investment Research
Waters Corp Price Target Raised to $500.00/Share From $460.00 by Barclays - Moomoo
Waters Corporation (WAT) Stock Forecasts - Yahoo Finance
Fidelity Advisor Health Care Fund's Waters Corp(WAT) Holding History - GuruFocus
Waters Corporation stock hits all-time high at 449.0 USD - Investing.com
CellCarta, Waters Corporation collaborate on companion diagnostics - Yahoo Finance
Waters Corp (WAT) Stock Up 3.5% but GF Value Says Overvalued -- GF Score: 94/100 - GuruFocus
Waters Corp. stock outperforms competitors on strong trading day - MarketWatch
Waters Corp stock after-hours at EUR 387.60: plus 2.57 percent - AD HOC NEWS
Should You Invest in the Invesco Water Resources ETF (PHO)? - Zacks Investment Research
Instead of cash director fees, Heather Knight receives 57.41 stock units at Waters (WAT). - Stock Titan
Stock replaces cash for director fees at Waters (WAT); Wei Jiang receives 57.41 units. - Stock Titan
Waters Corp (WAT) Shares Fall 3.1% -- What GF Score of 94 Tells Investors - GuruFocus
Waters Corp. stock outperforms competitors despite losses on the day - MarketWatch
Waters Corp Is Maintained at Buy by Guggenheim - Moomoo
An earnings call is set for Nov. 3; Waters' replay stays available until at least Dec. 1. - Stock Titan
Waters Corporation Schedules Third Quarter 2026 Earnings Conference Call - Yahoo Finance
Waters Corporation (WAT) Stock Forecasts - Yahoo Finance
If You Invested $1000 In Waters Stock 20 Years Ago, You Would Have This Much Today - Benzinga
Waters Corp (WAT): GF Score of 94 Signals Strong Outperformance Potential - GuruFocus
Waters Corp. stock outperforms competitors on strong trading day - MarketWatch
The Bull Case For Waters (WAT) Could Change Following New At-Home HPV And Cell Analysis Push - Yahoo! Finance Canada
The Bull Case For Waters (WAT) Could Change Following New At-Home HPV And Cell Analysis Push - Yahoo Finance
Waters Tops Growth Outlook as AI Demand, BD Integration Fuel Momentum - Yahoo Finance
Waters Corp. stock outperforms competitors on strong trading day - MarketWatch
Waters Corp. stock outperforms competitors on strong trading day - MarketWatch
Waters Corporation stock hits all-time high at 433.09 USD - Investing.com
Waters Corp stock rises 0.4 percent ahead of the open - ad-hoc-news.de
Waters Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Waters Corporation (WAT) stock price, news, quote and history - Yahoo Finance UK
Robust Results Lifted Waters (WAT) - Yahoo Finance
Waters Corp at JPMorgan U.S. All Stars Conference Transcript - GuruFocus
Waters Corp stock gains 3.35 percent as revenue recovery matters - AD HOC NEWS
Waters Corp stock heads into the open after a 1.9 percent drop - AD HOC NEWS
Waters Corp stock gains attention after new Outperform rating and USD 435 target - AD HOC NEWS
Waters Corp stock heads into the open after a 1.9 percent drop - AD HOC NEWS
Waters Stock Price Forecast. Should You Buy WAT? - StockInvest.us
Waters Launches BD FACSDiscover A7 for Advanced Flow Cytometry - Yahoo Finance
How Is Waters Corporation's Stock Performance Compared to Other Health Care Stocks? - Barchart.com
Waters Corp. stock outperforms competitors on strong trading day - MarketWatch
Waters Corp (WAT): GF Score of 94 Signals Strong Outperformance Potential - GuruFocus
Waters Corporation stock hits 52-week high at 427.1 USD - Investing.com
Waters Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Waters Corp. stock outperforms competitors on strong trading day - MarketWatch
Waters Corp stock gains after UBS upgrade and conference news - ad-hoc-news.de
Waters Corp CEO Udit Batra to speak at J.P. Mor... - Pluang
Waters Corporation to Present at the J.P. Morgan U.S. All Stars Conference - Yahoo Finance
Waters Corp stock heads into the open after a 0.6% dip - ad-hoc-news.de
Waters Corp Stock (WAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Waters Corp Stock (WAT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| KUEBLER CHRISTOPHER A | Director |
Aug 06 '26 |
Sale |
397.94 |
3,626 |
1,442,930 |
17,808 |
| KUEBLER CHRISTOPHER A | Director |
Aug 06 '26 |
Proposed Sale |
397.94 |
3,626 |
1,442,930 |
0 |
| Jiang Wei | Director |
Mar 16 '26 |
Buy |
289.46 |
500 |
144,730 |
3,441 |
| FEARON RICHARD H | Director |
Mar 06 '26 |
Buy |
306.34 |
1,000 |
306,340 |
3,302 |
| KUEBLER CHRISTOPHER A | Director |
Nov 05 '25 |
Option Exercise |
130.35 |
3,761 |
490,246 |
18,796 |
1.53%
2.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):